HK1256614A1 - 经取代的1,2-二氢-3h-吡咯并[1,2-c]咪唑-3-酮抗菌化合物 - Google Patents

经取代的1,2-二氢-3h-吡咯并[1,2-c]咪唑-3-酮抗菌化合物 Download PDF

Info

Publication number
HK1256614A1
HK1256614A1 HK18115746.5A HK18115746A HK1256614A1 HK 1256614 A1 HK1256614 A1 HK 1256614A1 HK 18115746 A HK18115746 A HK 18115746A HK 1256614 A1 HK1256614 A1 HK 1256614A1
Authority
HK
Hong Kong
Prior art keywords
pyrrolo
imidazol
dihydro
substituted
antibacterial compounds
Prior art date
Application number
HK18115746.5A
Other languages
English (en)
Chinese (zh)
Inventor
Anne-Catherine BLUMSTEIN
Gaelle Mathieu
Loic JACOB
Florence Masse
Azely MIRRE
Philippe Panchaud
Christine Schmitt
Jean-Philippe Surivet
Jean-Luc Specklin
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of HK1256614A1 publication Critical patent/HK1256614A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK18115746.5A 2015-09-03 2016-09-02 经取代的1,2-二氢-3h-吡咯并[1,2-c]咪唑-3-酮抗菌化合物 HK1256614A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2015070144 2015-09-03
EPPCT/EP2015/070144 2015-09-03
PCT/EP2016/070695 WO2017037221A1 (en) 2015-09-03 2016-09-02 Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds

Publications (1)

Publication Number Publication Date
HK1256614A1 true HK1256614A1 (zh) 2019-09-27

Family

ID=56852279

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18115746.5A HK1256614A1 (zh) 2015-09-03 2016-09-02 经取代的1,2-二氢-3h-吡咯并[1,2-c]咪唑-3-酮抗菌化合物

Country Status (17)

Country Link
US (1) US10314823B2 (cg-RX-API-DMAC7.html)
EP (1) EP3344630B1 (cg-RX-API-DMAC7.html)
JP (1) JP2018526391A (cg-RX-API-DMAC7.html)
KR (1) KR20180049017A (cg-RX-API-DMAC7.html)
CN (1) CN108137596A (cg-RX-API-DMAC7.html)
AR (1) AR105889A1 (cg-RX-API-DMAC7.html)
AU (1) AU2016313794B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018004343A2 (cg-RX-API-DMAC7.html)
CA (1) CA2994996A1 (cg-RX-API-DMAC7.html)
CL (1) CL2018000533A1 (cg-RX-API-DMAC7.html)
EA (1) EA201890626A1 (cg-RX-API-DMAC7.html)
HK (1) HK1256614A1 (cg-RX-API-DMAC7.html)
IL (1) IL257757A (cg-RX-API-DMAC7.html)
MX (1) MX2018002644A (cg-RX-API-DMAC7.html)
PH (1) PH12018500323A1 (cg-RX-API-DMAC7.html)
TW (1) TW201714885A (cg-RX-API-DMAC7.html)
WO (1) WO2017037221A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
TW201840569A (zh) * 2017-03-01 2018-11-16 瑞士商愛杜西亞製藥有限公司 (2r)-n-羥基-4-(6-((1-(2-羥基乙基)氮雜環丁烷-3-基)丁-1,3-二炔-1-基)-3-氧基-1h-吡咯并[1,2-c]咪唑-2(3h)-基)-2-甲基-2-(甲磺醯基)丁醯胺之結晶形式
WO2018224455A1 (en) 2017-06-07 2018-12-13 Basf Se Substituted cyclopropyl derivatives
WO2019038362A1 (en) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd ANTIBACTERIAL PYRROLOIMIDAZOLONES
WO2019086452A1 (en) 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds
WO2019121143A1 (en) 2017-12-20 2019-06-27 Basf Se Substituted cyclopropyl derivatives
JP7156199B2 (ja) * 2018-08-09 2022-10-19 信越化学工業株式会社 レジスト材料及びパターン形成方法
US11458149B1 (en) 2019-05-31 2022-10-04 Ikena Oncology, Inc. TEAD inhibitors and uses thereof
BR112021024108A2 (pt) 2019-05-31 2022-03-22 Ikena Oncology Inc Inibidores de tead e usos dos mesmos
US12703680B2 (en) 2019-11-21 2026-08-11 University Of Utah Research Foundation TRPV4 receptor ligands

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG2013013339A (en) 2002-03-13 2014-12-30 Array Biopharma Inc N3 alkylated benzimidazole derivatives as mek inhibitors
UA80500C2 (en) 2003-10-17 2007-09-25 Basf Ag Fungicidal mixture and agent for controlling rice pathogens, containing triazolopyrimidine derivative and metalaxyl-m, method for controlling rice pathogens and sowing material
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
CA2774250C (en) 2009-10-13 2013-12-17 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
JP5793766B2 (ja) 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なn−結合型ヒドロキサム酸誘導体
KR20120079015A (ko) 2011-01-03 2012-07-11 한미약품 주식회사 G 단백질-커플링된 수용체의 조절을 위한 신규한 비사이클릭 화합물
AP3336A (en) 2011-03-07 2015-07-31 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
WO2012137099A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
WO2012137094A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents
WO2013170165A1 (en) 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
EA201590953A1 (ru) 2012-11-16 2015-08-31 Бристол-Майерс Сквибб Компани Пирролидиновые модуляторы gpr40
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) * 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
WO2015066413A1 (en) 2013-11-01 2015-05-07 Novartis Ag Oxazolidinone hydroxamic acid compounds for the treatment of bacterial infections
KR20160098503A (ko) 2013-12-19 2016-08-18 액테리온 파마슈티칼 리미티드 항균성 1h-인다졸 및 1h-인돌 유도체
AR099612A1 (es) * 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
WO2015173329A1 (en) 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
BR112017010474A2 (pt) 2014-11-19 2017-12-26 Actelion Pharmaceuticals Ltd derivados antibacterianos de benzotiazol
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105839A1 (es) 2015-08-28 2017-11-15 Actelion Pharmaceuticals Ltd Derivados antibacterianos pirrolidin-2-ona anulares
AR105848A1 (es) 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
WO2017098440A1 (en) 2015-12-08 2017-06-15 Glaxosmithkline Intellectual Property Development Limited Substituted benzazinones as antibacterial compounds
AU2017267194A1 (en) 2016-05-17 2019-01-17 Idorsia Pharmaceuticals Ltd 6-(BUTA-1,3-DIYN-1-YL)benzo[D]thiazole derivatives

Also Published As

Publication number Publication date
US20180250273A1 (en) 2018-09-06
US10314823B2 (en) 2019-06-11
EA201890626A1 (ru) 2018-09-28
TW201714885A (zh) 2017-05-01
EP3344630A1 (en) 2018-07-11
CL2018000533A1 (es) 2018-06-29
AU2016313794A1 (en) 2018-04-19
BR112018004343A2 (pt) 2018-09-25
WO2017037221A1 (en) 2017-03-09
JP2018526391A (ja) 2018-09-13
IL257757A (en) 2018-04-30
KR20180049017A (ko) 2018-05-10
PH12018500323A1 (en) 2018-08-13
MX2018002644A (es) 2018-06-20
AR105889A1 (es) 2017-11-22
EP3344630B1 (en) 2020-12-09
AU2016313794B2 (en) 2020-06-04
CA2994996A1 (en) 2017-03-09
CN108137596A (zh) 2018-06-08

Similar Documents

Publication Publication Date Title
PH12018500323A1 (en) Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterial compounds
EA201791692A1 (ru) 4H-ПИРРОЛО[3,2-c]ПИРИДИН-4-ОНОВЫЕ ПРОИЗВОДНЫЕ
HK1217492A1 (zh) 作爲刺猬信号通路抑制剂的杂环化合物
EA201691913A1 (ru) Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов
HK1220355A1 (zh) Mk2抑制劑和其用途
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
PH12016500643A1 (en) New octahydro - cyclobuta [1,2-c;3,4-c`] dipyrrol -2- yl
WO2017015433A3 (en) Compound targeting il-23a and b-cell activating factor (baff) and uses thereof
PH12018500301A1 (en) Substituted 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one antibacterials
EA201692525A1 (ru) Замещенные соединения [1,2,4]триазола и имидазола в качестве фунгицидов
SA516371717B1 (ar) مشتقات 1، 2- داي هيدرو -3H- بيرولو [1، 2-c] إيميدازول -3- أون مضادة للبكتريا
WO2015171526A3 (en) Tricyclic pyrazolopyridine compounds
EA201692289A1 (ru) Замещенные [1,2,4]триазольные и имидазольные соединения в качестве фунгицидов
WO2015029074A3 (en) Compositions of eltrombopag
WO2015197534A3 (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2014108288A3 (en) Substituted imidazole and (1,2,4)triazole compounds as fungicides
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
WO2016055800A3 (en) Fluorescent synthetic retinoids
WO2016164295A3 (en) Fused pyridines as adaptor associated kinase 1 (aak1) inhibitors
WO2016014864A8 (en) Hydroxy-(r),(r)-2,2'-bismethylnaltrexones and uses thereof
WO2015144977A8 (en) Trpa1 modulators
WO2015102024A3 (en) Novel substituted 5 membered heterocyclic compounds and preparation thereof
MX2018014170A (es) Derivados 6-(buta-1,3-diin-1-il)benzo[d]tiazol.
WO2016023522A3 (en) Substituted phosphoramidate compounds and uses thereof
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole